| Literature DB >> 25617134 |
Annette Tennstaedt1, Markus Aswendt1, Joanna Adamczak1, Ursel Collienne2, Marion Selt1, Gabriele Schneider1, Nadine Henn1, Cordula Schaefer1, Marie Lagouge3, Dirk Wiedermann1, Peter Kloppenburg2, Mathias Hoehn4.
Abstract
Human neural stem cells (hNSCs) hold great promise for the treatment of neurological diseases. Considerable progress has been made to induce neural differentiation in the cell culture in vitro and upon transplantation in vivo [2] in order to explore restoration of damaged neuronal circuits. However, in vivo conventional strategies are limited to post mortem analysis. Here, we apply our developed first fate mapping platform to monitor neuronal differentiation in vivo by magnetic resonance imaging, bioluminescence imaging, and fluorescence imaging. Ferritin, Luciferase and GFP under neuronal-specific promoters for immature and mature neurons, respectively, were used to generate transgenic hNSCs. Differentiation-linked imaging reporter expression was validated in vitro. The time profile of spontaneous neuronal maturation after transplantation into mouse brain cortex demonstrated early neuronal differentiation within 6 weeks. Fully mature neurons expressing synaptogenesis were observed only after three months or longer. Our trimodal fate mapping strategy represents a unique non-invasive tool to monitor the time course of neuronal differentiation of transplanted stem cells in vivo.Entities:
Keywords: Doublecortin promoter; Human neural stem cells; In vivo bioluminescence imaging; Neuronal differentiation; Synapsin I promoter
Mesh:
Substances:
Year: 2015 PMID: 25617134 DOI: 10.1016/j.biomaterials.2014.12.038
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479